HPM
BLFS icon

Heights Point Management’s BioLife Solutions BLFS Stock Holding History

Heights Point Management’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.75M Buy
238,850
+5,872
+3% +$137K 5.37% 5
2026
Q1 		$4.45M Buy
232,978
+15,430
+7% +$341K 4.12% 14
2025
Q4 		$5.26M Buy
+217,548
New +$5.69M 4.49% 12

Other funds holding BLFS

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Heights Point Management's BLFS Position: Q2 2026 in Review

Heights Point Management increased its BioLife Solutions (BLFS) stake by 2.5% in Q2 2026, buying an estimated $137K and bringing the position to 238,850 shares worth $6.75M. The position accounts for 5.37% of the portfolio, ranked #5.

Heights Point Management first reported a position in BLFS in Q4 2025 and has held it in 3 quarters since. 216 funds tracked by Wall St. Rank hold BLFS as of Q2 2026.

  • Heights Point Management held 238,850 shares of BioLife Solutions worth $6.75M as of Q2 2026.
  • Heights Point Management bought 5,872 BioLife Solutions shares in Q2 2026, an estimated $137K.
  • BioLife Solutions made up 5.37% of Heights Point Management's portfolio in Q2 2026, its #5 holding.
  • Heights Point Management first reported a position in BioLife Solutions in Q4 2025 and has held it in 3 quarters since.
  • 216 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2026.

Based on Heights Point Management's 13F filing for Q2 2026, filed 14 Aug 2026.